Cargando…

Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions

Detalles Bibliográficos
Autores principales:	Mote, P, Clarke, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300802/ http://dx.doi.org/10.1186/bcr103

Ejemplares similares

Expression of Oct4A splicing variant in human bladder premalignant lesions predicts its invasiveness
por: Jóźwicki, Wojciech, et al.
Publicado: (2012)

Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression
por: Scarpin, Katherine M., et al.
Publicado: (2009)

Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells
por: Lange, CA, et al.
Publicado: (2000)

Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells
por: Graham, J Dinny, et al.
Publicado: (2002)

Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001)

Macrophages promote the progression of premalignant mammary lesions to invasive cancer
por: Carron, Emily C., et al.
Publicado: (2017)

Progesterone and interleukin-8 during and after cardiopulmonary bypass in infants and children
por: Trotter, A, et al.
Publicado: (1999)

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)

CD31 expression by cells of extensive ductal in situ and invasive carcinomas of the breast
por: Sapino, A, et al.
Publicado: (2001)

Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer
por: Hynes, NE, et al.
Publicado: (2001)

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer
por: Stal, O, et al.
Publicado: (2000)

Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Expression of cyclooxygenase-2 in gastritis and gastric premalignant lesions
por: Rossolymos, Nikolaos A., et al.
Publicado: (2013)

B-cell receptor signaling studies in patients with lupus: preliminary results
por: Faludi, M, et al.
Publicado: (2012)

Autoimmune progesterone dermatitis (AIPD) triggered by intrauterine device (IUD): case report
por: Bard De Carvalho, Ana Luiza Ribeiro, et al.
Publicado: (2015)

Minimally invasive treatment of the breast
por: Hall-Craggs, M
Publicado: (2000)

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells
por: Zeillinger, R, et al.
Publicado: (2000)

Premalignant Lesions as Targets for Cancer Vaccines
por: Finn, Olivera J.
Publicado: (2003)

Zoon's Balanitis: Benign or Premalignant Lesion?
por: Balato, Nicola, et al.
Publicado: (2009)

DNA integrity in diagnosis of premalignant lesions
por: Azab, Noha Adel, et al.
Publicado: (2021)

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
por: Mastracci, Teresa L, et al.
Publicado: (2007)

Intraductal Proliferative Lesions of the Breast—Terminology and Biology Matter: Premalignant Lesions or Preinvasive Cancer?
por: Costarelli, Leopoldo, et al.
Publicado: (2012)

E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study
por: Kalaimani, Gnanambigai, et al.
Publicado: (2023)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

Immunological and classical subtypes of oral premalignant lesions
por: Foy, Jean-Philippe, et al.
Publicado: (2018)

Cystitis glandularis: A controversial premalignant lesion
por: YI, XIANLIN, et al.
Publicado: (2014)

Premalignant lesions and gastric cancer: Current understanding
por: Koulis, Athanasios, et al.
Publicado: (2019)

Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
por: Xia, Juan, et al.
Publicado: (2012)

Diverse Macrophage Populations Contribute to the Inflammatory Microenvironment in Premalignant Lesions During Localized Invasion
por: Ibrahim, Ayman M., et al.
Publicado: (2020)

CD95 ligand expression in dedifferentiated breast cancer
por: Moers, C, et al.
Publicado: (2001)

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993)

Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
por: Walaszek, Kinga, et al.
Publicado: (2018)

miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions
por: Al-Eryani, Laila, et al.
Publicado: (2018)

The role of subareolar methylene blue in identifying the sentinel node in patients with invasive breast cancer
por: Mostafa, A, et al.
Publicado: (2001)

Understanding estrogen receptor transcription in breast cancer
por: Carroll, Jason S
Publicado: (2013)

The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice
por: Li, Y, et al.
Publicado: (2008)

Spontaneous apoptosis of circulating T-lymphocytes and its correlation to their prolactin receptor expression and prolactin plasma levels in patients with breast cancer
por: Bauernhofer, T, et al.
Publicado: (2001)

CD95 ligand expression mediates immune escape in breast cancer
por: Moers, C, et al.
Publicado: (2001)

Three-dimensional ultrasound-guided biopsy of breast lesion: a new diagnostic support in the preoperative diagnosis
por: Delle Chiaie, L, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_206i2nb05sc0c6r97etcrkfm08